跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,631 条关于
“Yoltech Therapeutics”
全部
16,631
临床试验
3,577
药物
3,116
机构
1,134
资讯
8,804
去年
Yoltech Therapeutics' YOLT-201 Shows Promise in Phase I ATTR Amyloidosis Trial
去年
YolTech Therapeutics Launches Clinical Trial for In Vivo Gene Editing Therapy YOLT-204 in Transfusion-Dependent Beta-Thalassemia
10个月前
YolTech Therapeutics Receives FDA Clearance for First Pivotal Trial of In Vivo Gene-Editing Therapy for Primary Hyperoxaluria Type 1
去年
YolTech Therapeutics Secures $45 Million Series B Funding to Advance In Vivo Gene Editing Pipeline
去年
Gene Editing Advances: Intellia, Poseida, YolTech, and KSQ Therapeutics Report Clinical Trial Updates
去年
YolTech's YOLT-203 Shows Promise in Primary Hyperoxaluria Type 1 with Positive Clinical Data
7个月前
YolTech's YOLT-202 Gene Editing Therapy Shows Promising Results in Alpha-1 Antitrypsin Deficiency Trial
去年
Non-Viral CRISPR Therapy Shows Promise for Primary Hyperoxaluria Type 1 in Preclinical Study
去年
CRISPR Weekly Roundup: Advancements in Gene Editing and Clinical Trials
2年前
First Patients Dosed in Phase 1 Trial of In Vivo CRISPR Therapy YOLT-203 for Primary Hyperoxaluria Type 1
第 1 页,共 881 页
上一页
下一页